Determining Scrotal Skin Necrosis
Scrotal skin necrosis is identified by characteristic physical examination findings including grayish or blackish-brown discoloration with sharp demarcation from surrounding normal skin, accompanied by induration, erythema, purulence, ulceration, and visible necrotic tissue 1.
Clinical Assessment
The physical examination provides the most direct evidence of necrosis:
- Skin color changes: Look for grayish, blackish-brown, or dusky discoloration that sharply contrasts with adjacent normal skin 1
- Tissue texture: Necrotic skin appears indurated (hardened) and may have a leathery consistency
- Associated findings: Erythema extending beyond the necrotic area, purulent drainage, ulceration, and frank necrotic tissue 1
- Crepitus: Palpable subcutaneous gas suggests necrotizing infection (Fournier's gangrene), though this may be a late finding 2, 3
Imaging Confirmation
When clinical findings are equivocal or to assess extent of disease:
Ultrasound is the primary imaging modality and can detect necrotizing infection before physical examination findings become obvious 3. Key ultrasonographic features include:
- Subcutaneous gas: Appears as hyperechoic foci with posterior shadowing or "dirty shadowing," indicating tissue necrosis 2, 3
- Fascial involvement: Evidence of fascial necrosis or fluid tracking along fascial planes 4
- Soft tissue thickening: Abnormal echogenicity in the scrotal wall
A critical pitfall: ultrasound can identify gas in soft tissues before crepitus is clinically detectable, enabling earlier diagnosis and intervention 3.
Systemic Indicators
Supporting laboratory findings that suggest necrotizing infection:
- Leukocytosis with left shift
- Elevated C-reactive protein 4
- Signs of sepsis or systemic toxicity
Clinical Context Matters
The presence of systemic symptoms (fever, malaise) combined with rapidly progressive scrotal pain and swelling should heighten suspicion for necrotizing fasciitis 4, 2. This represents a surgical emergency requiring immediate debridement, as delay significantly increases morbidity and mortality.
In neonates and immunocompromised patients (particularly those with poorly controlled diabetes), maintain an especially high index of suspicion as progression can be fulminant 2, 1.